ArticleArXiv2026
SAGE-FM: A lightweight and interpretable spatial transcriptomics foundation model.
Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Spatial transcriptomics enables spatial gene expression profiling, motivating computational models that capture spatially conditioned regulatory relationships. We introduce SAGE-FM, a lightweight spatial transcriptomics foundation model based on graph convolutional networks (GCN) trained with a masked-central-spot prediction objective. Trained on 416 human Visium samples spanning 15 organs, SAGE-FM learns spatially coherent embeddings that recover masked genes robustly, with 91% of masked genes showing significant correlations (p < 0.05). The SAGE-FM generated embeddings outperform MOFA and spatial transcriptomics in unsupervised clustering and preservation of biological heterogeneity. SAGE-FM generalizes to downstream tasks, enabling 81% accuracy in pathologist-defined spot annotation in oropharyngeal squamous cell carcinoma and improving glioblastoma subtype prediction relative to MOFA.
Indexed as
Identifiers
41647237PMC12869381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.